Access to UACI provides this startup with a structured incubation program, customized business support and the ability to work alongside UACI’s 36 other startups. UACI provides access to the people, programming and places needed to scale a business. Along with support, entrepreneurs have a direct line to funding opportunities and mentors who guide them in turning their idea into a product. Other tools the incubation program provides are office and lab space, a prototyping center and assistance through a 27-point roadmap that helps them with creating a business plan, identifying a target market, product development, marketing resources and much more.  

“We appreciate UACI and BIOSA for their trust in TheraCea technology and the team. We are very excited about this opportunity as the award provides us a well-equipped laboratory and office space to further develop TheraCea technology while we get support and help from business mentors and industry experts. We, at TheraCea, highly believe that moving to this new UACI facility in Oro Valley is a significant milestone in our progress toward achieving our goals,” expressed Iman Daryaei, Chief Executive Officer of TheraCea Pharma.

“Our team is thrilled to welcome TheraCea Pharma to the UACI family. Their novel technology addresses a real-world medical need, and they have the right team to execute. The fact that this technology was developed at the university, licensed through Tech Launch Arizona and is now about to grow in our incubator highlights how the university collectively serves innovation from idea to success,” stated Eric Smith, Executive Director, University of Arizona Center for Innovation.